0001493152-25-011598 | 10-Q | XBRL Viewer | Imunon INC

This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser.

Print Document
Reports Warrants Details Schedule of Warrant Activity (Details) Schedule of Lease Payments and Maturity of Operating Lease Liabilities (Details) Uncategorized Uncategorized Items - form10-q_htm.xml All Reports

Label

Element

Value

Change Increase (Decrease), Loss from operations, percentage

IMNN_IncreaseDecreaseInLossFromOperationsPercentage

(31.00%)

Options outstanding, issued

IMNN_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIssued

Change Increase (Decrease), Subtotal, percentage

IMNN_IncreaseDecreaseInOperatingCostsAndExpensesPercentage

Change Increase (Decrease), Subtotal, percentage

IMNN_IncreaseDecreaseInOperatingCostsAndExpensesPercentage

(47.00%)

Change Increase (Decrease), Subtotal, percentage

IMNN_IncreaseDecreaseInOperatingCostsAndExpensesPercentage

(96.30%)

Change Increase (Decrease), Subtotal, percentage

IMNN_IncreaseDecreaseInOperatingCostsAndExpensesPercentage

(13.50%)

Change Increase (Decrease), Subtotal, percentage

IMNN_IncreaseDecreaseInOperatingCostsAndExpensesPercentage

(49.60%)

Change Increase (Decrease), Subtotal, percentage

IMNN_IncreaseDecreaseInOperatingCostsAndExpensesPercentage

127.80%

Change Increase (Decrease), Subtotal, percentage

IMNN_IncreaseDecreaseInOperatingCostsAndExpensesPercentage

(32.00%)

Change Increase (Decrease), Subtotal, percentage

IMNN_IncreaseDecreaseInOperatingCostsAndExpensesPercentage

(40.50%)

NASDAQ capital market description

IMNN_NASDAQCapitalMarketDescription

The NASDAQ Capital Market, which requires that the Company comply with the applicable listing requirements under NASDAQ Marketplace Rules, which requirements include, among others, a minimum bid price of at least $1.00 per share. On November 26, 2024, the Company received a letter from NASDAQ indicating that the closing bid price of the Company’s Common Stock fell below $1.00 per share for the previous 30 consecutive business days, and that the Company was therefore not in compliance with the minimum bid price requirement for continued inclusion on The NASDAQ Capital Market. The Company had 180 calendar days, until May 27, 2025, to regain compliance with this requirement, which occurs when the closing bid price of the Company’s Common Stock is at least $1.00 per share for a minimum of ten consecutive business days during the 180-day compliance period. As of May 27, 2025, we were not eligible for an additional 180 calendar day compliance period, as we did not meet the required Nasdaq initial listing standards, and, on May 28, 2025, we received a delisting notice from Nasdaq. We also received a notice from the Staff notifying us that, because our stockholders’ equity was below $2.5 million as reported on our Quarterly Report on Form 10-Q for the quarter ended March 31, 2025, we no longer meet the minimum stockholders’ equity requirement for continued listing on Nasdaq under Nasdaq Rule 5550(b)(1).

Change Increase (Decrease), Research and development expenses

IMNN_IncreaseDecreaseInOperatingCostAndExpenses

$ (339,000)

Change Increase (Decrease), Research and development expenses

IMNN_IncreaseDecreaseInOperatingCostAndExpenses

(856,000)

Change Increase (Decrease), Research and development expenses

IMNN_IncreaseDecreaseInOperatingCostAndExpenses

(149,000)

Change Increase (Decrease), Research and development expenses

IMNN_IncreaseDecreaseInOperatingCostAndExpenses

(1,344,000)

Change Increase (Decrease), Research and development expenses

IMNN_IncreaseDecreaseInOperatingCostAndExpenses

833,000

Change Increase (Decrease), Research and development expenses

IMNN_IncreaseDecreaseInOperatingCostAndExpenses

(1,956,000)

Change Increase (Decrease), Research and development expenses

IMNN_IncreaseDecreaseInOperatingCostAndExpenses

(255,000)

Change Increase (Decrease), Research and development expenses

IMNN_IncreaseDecreaseInOperatingCostAndExpenses

(1,378,000)

Change Increase (Decrease), Research and development expenses

IMNN_IncreaseDecreaseInOperatingCostAndExpenses

$ (2,722,000)

Non-Rule 10b5-1 Arrangement Modified

IMNN_NonRule10b51ArrModifiedFlag

false

Options outstanding

IMNN_OptionsOutstanding

$ 1,900,000

Options outstanding

IMNN_OptionsOutstanding

100,000

IssuanceOfCommonStockUponExerciseOfRestrictedOptions

IMNN_IssuanceOfCommonStockUponExerciseOfRestrictedOptions

IssuanceOfCommonStockUponExerciseOfRestrictedOptions

IMNN_IssuanceOfCommonStockUponExerciseOfRestrictedOptions

IssuanceOfCommonStockUponExerciseOfRestrictedOptions

IMNN_IssuanceOfCommonStockUponExerciseOfRestrictedOptions

IssuanceOfCommonStockUponExerciseOfRestrictedOptions

IMNN_IssuanceOfCommonStockUponExerciseOfRestrictedOptions

IssuanceOfCommonStockUponExerciseOfRestrictedOptions

IMNN_IssuanceOfCommonStockUponExerciseOfRestrictedOptions

IssuanceOfCommonStockUponExerciseOfRestrictedOptions

IMNN_IssuanceOfCommonStockUponExerciseOfRestrictedOptions

IssuanceOfCommonStockUponExerciseOfRestrictedOptions

IMNN_IssuanceOfCommonStockUponExerciseOfRestrictedOptions

IssuanceOfCommonStockUponExerciseOfRestrictedOptions

IMNN_IssuanceOfCommonStockUponExerciseOfRestrictedOptions

10

IssuanceOfCommonStockUponExerciseOfRestrictedOptions

IMNN_IssuanceOfCommonStockUponExerciseOfRestrictedOptions

10

IssuanceOfCommonStockUponExerciseOfRestrictedOptions

IMNN_IssuanceOfCommonStockUponExerciseOfRestrictedOptions

1

IssuanceOfCommonStockUponExerciseOfRestrictedOptions

IMNN_IssuanceOfCommonStockUponExerciseOfRestrictedOptions

1

Recognition of operating lease right-of-use asset and liability

IMNN_RecognitionOfRightUseAssetAndLiability

Recognition of operating lease right-of-use asset and liability

IMNN_RecognitionOfRightUseAssetAndLiability

$ 274,295

Change Increase (Decrease), Research and development expenses, percentage

IMNN_IncreaseDecreaseInResearchAndDevelopmentExpensesPercentage

(44.50%)

Schedule of Stock Options Awards and Restricted Stock Grants

IMNN_SummaryOfStockOptionAndRestrictedStockAwardsTableTextBlock

A summary of stock option awards and restricted stock grants, inclusive of awards granted under the 2018 Stock Plan and Inducement Option Grants for the six-months ended June 30, 2025 is presented below:

		Stock Options								Restricted Stock Awards								Weighted Average
		Options Outstanding				Weighted Average Exercise Price				Non-vested Restricted Stock Outstanding				Weighted Average Grant Date Fair Value				Contractual Terms of Equity Awards (in years)
Equity awards outstanding at January 1, 2025			109,725			$	29.31				2,647			$	14.85

Equity awards granted			21,449			$	12.96				-			$	-

Equity awards issued			-				-				980			$	14.85

Equity awards terminated			(5,050	)		$	27.88				-			$	-

Equity awards outstanding at June 30, 2025			126,124			$	26.59				1,667			$	14.85				8.7

Equity awards exercisable at June 30, 2025			78,453			$	32.70												8.1

Aggregate intrinsic value of equity awards exercisable at June 30, 2025		$	-

[custom:CommonStockOutstandingPercentage-0]

IMNN_CommonStockOutstandingPercentage

19.98%

Change Increase (Decrease), General and administrative expenses

IMNN_IncreaseDecreaseInGeneralAndAdministrativeExpenes

$ (390,000)

Issuance of common stock upon exercise of common stock warrants, shares

IMNN_IssuanceOfCommonStockUponExerciseOfCommonStockWarrantsShares

260,323

Issuance of common stock upon exercise of common stock warrants, shares

IMNN_IssuanceOfCommonStockUponExerciseOfCommonStockWarrantsShares

260,323

Issuance of common stock upon exercise of common stock warrants

IMNN_IssuanceOfCommonStockUponExerciseOfCommonStockWarrants

Issuance of common stock upon exercise of common stock warrants

IMNN_IssuanceOfCommonStockUponExerciseOfCommonStockWarrants

Issuance of common stock upon exercise of common stock warrants

IMNN_IssuanceOfCommonStockUponExerciseOfCommonStockWarrants

Issuance of common stock upon exercise of common stock warrants

IMNN_IssuanceOfCommonStockUponExerciseOfCommonStockWarrants

Issuance of common stock upon exercise of common stock warrants

IMNN_IssuanceOfCommonStockUponExerciseOfCommonStockWarrants

2,603

Issuance of common stock upon exercise of common stock warrants

IMNN_IssuanceOfCommonStockUponExerciseOfCommonStockWarrants

1,965,091

Issuance of common stock upon exercise of common stock warrants

IMNN_IssuanceOfCommonStockUponExerciseOfCommonStockWarrants

1,967,694

Issuance of common stock upon exercise of common stock warrants

IMNN_IssuanceOfCommonStockUponExerciseOfCommonStockWarrants

2,603

Issuance of common stock upon exercise of common stock warrants

IMNN_IssuanceOfCommonStockUponExerciseOfCommonStockWarrants

1,965,091

Issuance of common stock upon exercise of common stock warrants

IMNN_IssuanceOfCommonStockUponExerciseOfCommonStockWarrants

1,967,694

Prospectus supplement covers aggregate shares

IMNN_AggregateShares

8,184,733

Stock awards reduced

IMNN_StockAwardsReduced

12,700,000

Stock awards reduced

IMNN_StockAwardsReduced

$ 800,000

Rule 10b5-1 Arrangement Modified

IMNN_Rule10b51ArrModifiedFlag

false

Weighted average exercise price, issued

IMNN_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionIssuedWeightedAverageExercisePrice

Remaining amount

IMNN_RemainingShareAmount

$ 3,684,733

Change Increase (Decrease), Operating expenses

IMNN_IncreaseDecreaseInOperatingExpenses

(3,112,000)

Additional prospectus supplement amount

IMNN_AdditionalProspectusSupplementAmount

$ 4,500,000

Change Increase (Decrease), General and administrative expenses, percentage

IMNN_IncreaseDecreaseInGeneralAndAdministrativeExpensesPercentage

(10.00%)

Dividend per share

IMNN_DividendsCommonStocktPerShare

$ 0.15

Proceeds from issuance of common stock upon exercise of warrants

IMNN_ProceedsFromIssuanceOfCommonStockUponExerciseOfWarrants

Proceeds from issuance of common stock upon exercise of warrants

IMNN_ProceedsFromIssuanceOfCommonStockUponExerciseOfWarrants

$ 1,967,694

Non-vested stock awards, issued

IMNN_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIssued

980

Cumulative net loss

IMNN_CumulativeNetIncomeLoss

$ 414,000,000

Weighted average grant date fair value, issued

IMNN_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIssuedWeightedAverageGrantDateFairValue

$ 14.85

Change Increase (Decrease), Loss from operations

IMNN_IncreaseDecreaseInLossFromOperations

$ (3,112,000)

Stock dividend percentage

IMNN_StockDividendRatePercentage

15.00%

Change Increase (Decrease), Operating expenses, percentage

IMNN_IncreaseDecreaseInOperatingExpensesPercentage

(31.00%)

Schedule of Warrant Activity (Details)	6 Months Ended
Schedule of Warrant Activity (Details)	Jun. 30, 2025 USD ($) $ / shares shares
Warrants
Weighted Average Exercise Price, Warrants outstanding, Beginning balance	$ 37.65
Weighted Average Exercise Price, Warrants issued	$ 5.22
Number of Warrants Issued, Warrants exercised cashless \| shares	(194,734)
Weighted Average Exercise Price, Warrants exercised cashless
Weighted Average Exercise Price, Warrants exercised	5.44
Weighted Average Exercise Price, Warrants outstanding, Ending balance	$ 11.07
Aggregate intrinsic value of outstanding warrants \| $	$ 5,141,320
Weighted average remaining contractual terms (years)	3 years 1 month 6 days